• 873 Citations
20112022
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

I am dedicated to providing the high-quality and compassionate care for patients with breast cancer. I am interested in clinical research with a focus on developing clinical trials of novel agents for the treatment of all stages of breast cancer and investigating biomarkers to guide therapy decisions.

Training Experience

2014Residency, Northwestern University, McGaw Medical Center
2018Fellowship, Northwestern University, McGaw Medical Center

Education/Academic qualification

MD, Northwestern University Feinberg School of Medicine

… → 2011

Fingerprint Dive into the research topics where Ami N Shah is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Breast Neoplasms Medicine & Life Sciences
Heart Failure Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Registries Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Alveolar Rhabdomyosarcoma Medicine & Life Sciences
Hospitalization Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2019 2022

Research Output 2011 2019

  • 873 Citations
  • 10 Article
  • 7 Review article
  • 2 Chapter

Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer

Davis, A. A., Zhang, Q., Gerratana, L., Shah, A. N., Zhan, Y., Qiang, W., Finkelman, B. S., Flaum, L., Behdad, A., Gradishar, W. J., Platanias, L. C. & Cristofanilli, M., Dec 4 2019, In : Breast Cancer Research. 21, 1, 137.

Research output: Contribution to journalArticle

Open Access
Circulating Neoplastic Cells
Breast Neoplasms
DNA
Neoplasms
Nonparametric Statistics
1 Citation (Scopus)

Emerging Role of Genomics and Cell-Free DNA in Breast Cancer

Gerratana, L., Davis, A. A., Shah, A. N., Lin, C., Corvaja, C. & Cristofanilli, M., Aug 1 2019, In : Current treatment options in oncology. 20, 8, 68.

Research output: Contribution to journalReview article

Genomics
Breast Neoplasms
Precision Medicine
DNA
Neoplasms

Inhibitors of Tumor Angiogenesis

Shah, AN. & Gradishar, WJ., 2019, Cancer Chemotherapy, Immunotherapy, and Biotherapy: Principles and Practice, 6th edition. Chabner, B. & Longo, DL. (eds.). Philadelphia: Wolters Kluwer

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Adjuvant Anthracyclines in Breast Cancer: What Is Their Role?

Shah, A. N. & Gradishar, W. J., Aug 17 2018, In : The oncologist.

Research output: Contribution to journalArticle

Anthracyclines
Breast Neoplasms
Cyclophosphamide
Therapeutics
Lymph Nodes
5 Citations (Scopus)

Anaplastic lymphoma kinase mutation (ALK F1174C) in small cell carcinoma of the prostate and molecular response to alectinib

Carneiro, B. A., Pamarthy, S., Shah, A. N., Sagar, V., Unno, K., Han, H. Y., Yang, X. J., Costa, R. B., Nagy, R. J., Lanman, R. B., Kuzel, T. M., Ross, J. S., Gay, L., Elvin, J. A., Ali, S. M., Cristofanilli, M., Chae, Y. K., Giles, F. J. & Abdulkadir, S. A., Jun 15 2018, In : Clinical Cancer Research. 24, 12, p. 2732-2739 8 p.

Research output: Contribution to journalArticle

Small Cell Carcinoma
Prostate
Mutation
Organoids
Prostatic Neoplasms